CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-21). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 983 · Search date 2026-07-21 · Methodology v0.6

AAKG,
does it really help with Improved bench-press and leg-press maximal strength and repetition performance when taken before exercise?

30-Second Summary
C
Evidence Grade C · 40 · Safety caution
Mechanistic pump claims do not establish that one preworkout dose of AAKG improves bench- or leg-press strength or repetitions
What the
research shows
This claim is rated C. A randomized double-blind crossover trial in 16 men found that 3 g of AAKG taken 45 minutes before exercise did not improve bench-press or leg-press one-repetition maximum or total load to failure at 60% of maximum. However, an eight-week trial of 12 g daily in 35 men reported partial positive results for bench-press maximum and Wingate peak power. The directly matched acute trial was null, but the small longer trial was positive on selected outcomes, making the evidence conflicting and limited rather than a large human null result; the verdict therefore sits at the bottom of C. Leg-press maximal strength and repetition performance remain D as individual subclaims because their direct results were null. Gastrointestinal upset, diarrhea, nausea, possible blood-pressure lowering, and variation in product content and mixtures are safety and product-quality issues separate from efficacy.
What the
ads claim
Marketing converts nitric-oxide explosion, pump, or blood-flow language directly into heavier maximum lifts and more repetitions. Even if plasma arginine or the sensation of a pump changes, actual bench-press or leg-press performance does not necessarily improve, and the direct trial did not establish that link.
*

Useful facts when choosing a product

  • AAKG is a salt of L-arginine and alpha-ketoglutarate sold as a sports supplement and is not a medicine approved to improve exercise performance.
  • Research doses range from an acute 3 g to 12 g daily for eight weeks, while commercial preworkouts often add caffeine, citrulline, creatine, and other ingredients whose effects cannot be attributed to AAKG.
  • Actual AAKG content, ingredient ratio, and third-party quality testing vary among products, so results from one research formulation cannot be generalized to every supplement.
  • Nausea, abdominal pain, bloating, diarrhea, and headache can occur, and additive blood-pressure lowering may occur with antihypertensives, nitrates, or erectile-dysfunction medicines; people with disease or medication use should seek clinical advice.
Gap Measurement · Verdict 983 · C 40
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Wax and colleagues gave 3 g AAKG or placebo 45 minutes before testing in a crossover study of eight resistance-trained and eight untrained men. Bench-press and leg-press one-repetition maximum and total load performed to failure at 60% of maximum did not differ by supplementation condition. Campbell and colleagues assigned 35 resistance-trained men to 12 g AAKG daily or placebo during eight weeks of training; bench-press maximum and Wingate peak power were positive, but isokinetic quadriceps endurance, body composition, and aerobic capacity were not. The acute maximal-strength and repetition claim is therefore directly null, while the longer high-dose partial signal requires replication. Prior verdict 526 on arginine silicate and pump or blood-flow outcomes concerns a different endpoint and branded ingredient axis, not AAKG bench- and leg-press performance.

02

Why this is classified as C (40)

The precisely matched 16-person acute randomized crossover trial was null for bench-press and leg-press maximum and repetition load. A 35-person eight-week trial nevertheless reported a partial positive result for bench-press maximum, so the human evidence cannot be classified as a large null result. Small samples, different dosing and endpoints, and lack of independent replication make the evidence conflicting and limited, yielding C with 40 points. Gastrointestinal effects and product variation remain independent safety and quality issues.

Counterpoint. Progressive resistance training, adequate protein and energy, sleep, and evidence-based use of creatine where appropriate have a firmer basis and should not be replaced by AAKG.

Rejudgment record. Cross-check revision — The directly matched acute trial was null in 16 participants for bench-press and leg-press one-repetition maximum and total repetition load, but the 35-person eight-week trial was partly positive for bench-press maximum. This is conflicting and limited evidence at the bottom of C, not the large human null evidence required for D

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved bench-press maximal strength from preworkout AAKGCThe acute direct trial was null, but a small eight-week high-dose trial was partly positive for bench-press maximum, supporting C.
Improved leg-press maximal strength from preworkout AAKGDRemains D because leg-press one-repetition maximum did not differ from placebo in the direct crossover trial.
Improved bench- and leg-press repetition performance from preworkout AAKGDRemains D because total load to failure at 60% of maximum did not improve versus placebo for either exercise.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Wax B et al. 2012Randomized double-blind placebo-controlled crossover trial8Funding source not stated in the PubMed recordBench- and leg-press one-repetition maximum and total load to failure at 60% of maximum 45 minutes after 3 g AAKGNeither one-repetition maximum nor total load differed between AAKG and placebo regardless of training status.Most directly matched null randomized trial
Campbell B et al. 2006Eight-week randomized double-blind placebo-controlled trial15Specific funding source not stated in the PubMed abstract; product-focused studyBench-press one-repetition maximum, isokinetic quadriceps endurance, Wingate power, and body compositionBench-press maximum and Wingate peak power were positive, while quadriceps endurance, body composition, and aerobic capacity were null.Small partial positive evidence on an indirect dosing axis
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-21).

Wax B, Kavazis AN, Webb HE, Brown SP. Acute L-arginine alpha ketoglutarate supplementation fails to improve muscular performance in resistance trained and untrained men. J Int Soc Sports Nutr. 2012;9(1):17. PMID: 22510253. PMCID: PMC3428651. DOI: 10.1186/1550-2783-9-17.
checked
Campbell B, Roberts M, Kerksick C, et al. Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. Nutrition. 2006;22(9):872-881. PMID: 16928472. DOI: 10.1016/j.nut.2006.06.003.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-21 · Corrections: none

Cite this verdict

AAKG x preworkout bench-press and leg-press strength and repetitions Evidence Grade C card
[Chamgap] AAKG x preworkout bench-press and leg-press strength and repetitions — Evidence Grade C·40. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/sports/aakg-preworkout-bench-leg-press-strength-repetitions/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.